Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chi, S. L.
Right arrow Articles by Pizzo, S. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chi, S. L.
Right arrow Articles by Pizzo, S. V.
[Cancer Research 66, 875-882, January 15, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Angiostatin Is Directly Cytotoxic to Tumor Cells at Low Extracellular pH: A Mechanism Dependent on Cell Surface–Associated ATP Synthase

Sulene L. Chi and Salvatore V. Pizzo

Department of Pathology, Duke University Medical Center, Durham, North Carolina

Requests for reprints: Salvatore V. Pizzo, Department of Pathology, Duke University Medical Center, Box 3712, Research Drive, Durham, NC 27710. Phone: 919-684-3529; Fax: 919-684-8689; E-mail: pizzo001{at}mc.duke.edu.

Angiostatin, a proteolytic fragment of plasminogen, is a potent angiogenesis inhibitor able to suppress tumor growth and metastasis through inhibition of endothelial cell proliferation and migration. Previously, we showed that angiostatin binds and inhibits F1Fo ATP synthase on the endothelial cell surface and that anti-ATP synthase antibodies reduce endothelial cell proliferation. ATP synthase also occurs on the extracellular surface of a variety of cancer cells, where its function is as yet unknown. Here, we report that ATP synthase is present and active on the tumor cell surface, and angiostatin, or antibody directed against the catalytic ß-subunit of ATP synthase, inhibits the activity of the synthase. We show that tumor cell surface ATP synthase is more active at low extracellular pH (pHe). Low pHe is a unique characteristic of the tumor microenvironment. Although the mechanism of action of angiostatin has not been fully elucidated, angiostatin treatment in combination with acidosis decreases the intracellular pH (pHi) of endothelial cells, leading to cell death. We also find that, at low pHe, angiostatin and anti-ß-subunit antibody induce intracellular acidification of A549 cells, as well as a direct cytotoxicity that is absent in tumor cells with low levels of extracellular ATP synthase. These results establish angiostatin as an antitumorigenic and antiangiogenic agent through a mechanism implicating tumor cell surface ATP synthase. Furthermore, these data provide evidence that extracellular ATP synthase plays a role in regulating pHi in cells challenged by acidosis. (Cancer Res 2006; 66(2): 875-82)




This article has been cited by other articles:


Home page
BloodHome page
Y. M. Mowery and S. V. Pizzo
The antitumorigenic trifecta
Blood, August 27, 2009; 114(9): 1727 - 1728.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K Yamahara, K D Min, H Tomoike, K Kangawa, S Kitamura, and N Nagaya
Pathological role of angiostatin in heart failure: an endogenous inhibitor of mesenchymal stem-cell activation
Heart, February 1, 2009; 95(4): 283 - 289.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Li, Y.-H. Liu, S.-J. Lee, T. A. Gardner, M.-H. Jeng, and C. Kao
Prostate-Restricted Replicative Adenovirus Expressing Human Endostatin-Angiostatin Fusion Gene Exhibiting Dramatic Antitumor Efficacy
Clin. Cancer Res., January 1, 2008; 14(1): 291 - 299.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Mei, C. Wood, M. R. L'Abbe, G. S. Gilani, G. M. Cooke, I. H. Curran, and C. W. Xiao
Consumption of Soy Protein Isolate Modulates the Phosphorylation Status of Hepatic ATPase/ATP Synthase {beta} Protein and Increases ATPase Activity in Rats
J. Nutr., September 1, 2007; 137(9): 2029 - 2035.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. L. Chi, M. L. Wahl, Y. M. Mowery, S. Shan, S. Mukhopadhyay, S. C. Hilderbrand, D. J. Kenan, B. D. Lipes, C. E. Johnson, M. F. Marusich, et al.
Angiostatin-Like Activity of a Monoclonal Antibody to the Catalytic Subunit of F1F0 ATP Synthase
Cancer Res., May 15, 2007; 67(10): 4716 - 4724.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. E. Quillen, G. C. Haslam, H. S. Samra, D. Amani-Taleshi, J. A. Knight, D. E. Wyatt, S. C. Bishop, K. K. Colvert, M. L. Richter, and P. A. Kitos
Ectoadenylate Kinase and Plasma Membrane ATP Synthase Activities of Human Vascular Endothelial Cells
J. Biol. Chem., July 28, 2006; 281(30): 20728 - 20737.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.